Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 51-100 of 252 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Individualized dosing of serotherapy in allogeneic hematopoietic cell transplantationAdmiraal R., PhDKnibbe C.A.J., prof. dr.Boelens J.J., dr.Bredius R.G.M., dr.Universiteit Leiden (UL)2017ATG; Population PK; Stem cell transplantation; Immune reconstitution; Serotherapy;
ColoPulse tablets in inflammatory bowel disease: formulation, potential application and evaluationMaurer J.M., PhDKosterink J.G.W., prof. dr.Frijlink H.W., prof. dr.Woerdenbag H.J., dr.Rijksuniversiteit Groningen (RUG)2017ColoPulse tablets; Inflammatory bowel disease;
Exploring optimal pharmacotherapy after bariatic surgery: where two worlds meetYska J.P., PhDRoon E.N. van, prof. dr.Wilffert B, prof. dr.Rijksuniversiteit Groningen (RUG)2017Optimal pharmacotherapy; Bariatric surgery;
Variability in drug response: personalized diabetes carePetrykiv S.I.Lambers Heerspink H.J., prof. dr.Zeeuw D. de, prof. dr.Laverman G.D., dr.Rijksuniversiteit Groningen (RUG)2017
Techniques to improve neurological outcome after cardiac surgeryKok W.F., PhDHenning R.H., prof. dr.Absalom A.R., prof. dr.Scheeren T.W.L., prof. dr.Rijksuniversiteit Groningen (RUG)2017Cardiac surgery; Clinical pharmacology; Neurological outcome;
Towards better fall prevention - examining the interplay between factors that influence gait in older patientsGroot M.H. de, PhDBeijnen J.H., prof. dr.Lamoth C.J.C., dr.Universiteit Utrecht (UU)2017Falls; Gait analysis; Accelerometry; Frailty; Osteoporosis; Maturation; Medication use; Medication use; Geriatrics; Older patients;
Clinical pharmacology and bioanalysis of antileishmanial drugs : Towards improved treatment strategies for leishmaniasisKip A.E., PhDBeijnen J.H., prof. dr.Schellens J.H.M., prof. dr.Dorlo T.P.C., dr.Universiteit Utrecht (UU)2017Leishmaniasis; Clinical pharmacology; Bioanalysis; Pharmacokinetics; Pharmacodynamics; Miltefosine; Amphotericin B; Neopterin;
Antiplatelet drugs for secondary prevention of cardiovascular diseases : drug utilization, effectiveness, and safetyNoorsyahdy A.Y., MD PhDBoer A. de, prof. dr.Klungel O.H., prof. dr.Deneer V.H.M., dr.Universiteit Utrecht (UU)2017Antiplatelet drugs; Secondary prevention; Myocardial infarction; Ischemic stroke; Cardiac arrest; Pharmacogenetics;
Solid dispersions in oncology: a solution to solubility-limited oral drug absorptionSawicki E., PhDBeijnen J.H., prof. dr.Schellens J.H.M., prof. dr.Nuijen B., dr.Universiteit Utrecht (UU)2017Solid dispersions; Pharmacokinetics; Spray drying; Freeze drying; Docetaxel; Paclitaxel; Elacridar;
Paving ways for personalizing drug therapy during pregnancyDaud N.A.A., PhDWilffert B, prof. dr.Kammen-Bergman J.E.H. van, dr.Rijksuniversiteit Groningen (RUG)2017Personalized medicine; Drug therapy; Pregnancy;
Multimodality ImAging of Cardiovascular Dysfunction: Risk factors, diagnostics and treatment optionsThiel B.S. van, PhDKanaar R., prof. dr.Danser A.H.J., prof. dr.Essers J., dr.Pluijm I. van der, dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Imaging; Aging; Risk factors; Diagnostics; Treatment options
Unravelling the link between diabetes, insulin treatment and breast cancerBronsveld H.K., PhDBoer A. de, prof. dr.Bruin M.L. de, prof. dr.Schmidt M.K., dr. ir.Universiteit Utrecht (UU)2017Breast cancer; Risk factors; Diabetes mellitus; Insulin growth factor; Diabetes treatment;
Pharmacogenetics of sunitinib in metastatic renal cell carcinomaDiekstra M.H.M., drGuchelaar H.J., prof. dr.Swen J.J., PhDUniversiteit Leiden (UL)2017Genetics; Pharmacogenetics; Renal function;
Renin-Synthesizing Cells and BeyondGoes Martini A., PhDDanser A.H.J., prof. dr.Neves F.A.R., prof. dr.Erasmus Universiteit Rotterdam (EUR)2017Renin-angiotensin system; Renal function;
Multimodality ImAging of Cardiovascular Dysfunction: Risk Factors, Diagnostics and Treatment OptionsThiel B.S. van, PhDKanaar R., prof. dr.Danser A.H.J., prof. dr.Essers J., dr.Pluijm I. van der, dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Risk factors; Treatment options;
DNA Damage-related Vascular Dysfunction: Pathways and InterventionsBautista-Niño P.K., PhDDanser A.H.J., prof. dr.Franco Duran O.H., Prof.dr.Roks A.J.M., dr.Ghanbari M., dr.Erasmus Universiteit Rotterdam (EUR)2017Cardiovascular disease; Vascular reactivity; DNA damage;
Challenges in using cardiovascular medications in Sub-Saharan AfricaBerhe D.F., PhDHaaijer-Ruskamp F.M., prof. dr.Taxis K., prof. dr.Mol P.G.M., dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; Medication use; Cardiovascular disease;
Evaluation of renal end points in nephrology trials. Weldegiorgis MLambers Heerspink H.J., prof. dr.Zeeuw D. de, prof. dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; Nephrology trials; renal endpoints
Exploring strategies to individualize treatment with aminoglycosides and co-trimoxazole for MDR TuberculosisDijkstra J.A., PhDWerf T.S. van der, prof. dr.Kosterink J.G.W., prof. dr.Alffenaar J.W.C., prof. dr.Rijksuniversiteit Groningen (RUG)2017Personalized medicine; Tuberculosis;
Prediction and monitoring of chronic kidney diseaseBoele-Schutte E., PhDGansevoort R.T., prof. dr.Wolffenbuttel B.H.R., prof. dr.Lambers Heerspink H.J., prof. dr.Lutgers H.L., dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; Prediction; Kidney disease;
Advanced vascular imaging : technical and clinical applications in type 2 diabetesBoer S.A. de, PhDKamphuisen T.P.W., prof. dr.Slart R.H.J.A., prof. dr.Rijksuniversiteit Groningen (RUG)2017Pharmacology; advanced vascular imaging; Diabetes mellitus;
Preclinical molecular imaging of target expression and target dynamics in cancer. Pool M., PhDVries E.G.E. de, prof. dr.Lub-de Hooge M.N., dr.Terwisscha van Scheltinga A.G.T., PhDRijksuniversiteit Groningen (RUG)2017
Towards understanding interchangeability of generic drugsYu Y, drNeef C., prof. dr.Burger D.M., prof. dr.Universiteit Maastricht (UM)2017
Assessing the impact of gout:validating and understanding outcomesSpaetgens B.P.A., drBoonen A.E.R.C.H., prof. dr.Vries F. de, prof. dr.Universiteit Maastricht (UM)2017
Pharmacy Preparations: European quality standards and regulationScheepers H., drNeef C., prof. dr.Universiteit Maastricht (UM)2017Pharmacy policy;
Trials & tribulations : studies on the fate, transparency and efficiency of clinical drug trialsBogert C.A. van den, PhDLeufkens H.G.M., prof. dr.Souverein P.C., dr.Janssen S.W.J., dr.Universiteit Utrecht (UU)2017Clinical trials; Drug development; Publication bias; Regulatory science;
Readmission to primary care : the role of community pharmacists post-dischargeEnsing H.T., PhDBouvy M.L., prof. dr.Koster E.S., PhDDooren A.A. van, dr.Universiteit Utrecht (UU)2017Safety; Care continuity; Discharge; Pharmacist home visit;
Clinical decision support in community pharmacyHeringa M., PhDBouma H.R., PhDSmet P.A.G.M. de, prof. dr.Floor-Schreudering A., PhD PharmDUniversiteit Utrecht (UU)2017Patient safety; Clinical decision support system; Community pharmacy; Drug therapy;
Priority medicines for children : exploring age-appropriate medicines and antibiotic use in childrenIvanovska V., PhDLeufkens H.G.M., prof. dr.Mantel-Teeuwisse A.K., dr.Dijk C.E.M.J. van, dr. ir.Universiteit Utrecht (UU)2017Paediatric pharmacotherapy; Paediatric drug development; Priority setting; Age-appropriate formulations; Antibiotic use; Children;
The pursuit of user-friendly medicines : older people in the hot seatNotenboom K., PhDBouvy M.L., prof. dr.Leufkens H.G.M., prof. dr.Universiteit Utrecht (UU)2017Usability; User-friendly; Older patients; Elderly; Medicines; Medication use; Medication errors; Tablet breaking; Swallowing; Medication packaging;
Clinical Pharmacology of immuno-modulatory biotherapeuticsBurggraaf J., prof. dr.Burggraaf J., prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2017Immuno-modulatory biotherapeutics
Immunological aspects of conventional and new treatments for cervical cancer, an immunopharmacological approachMeir H. vanBurg S.H van der, Prof.dr.Burggraaf J., prof. dr.Kalkman C.J., prof. dr.Peeters M.Y.M., dr.2017Immunotherapy Combined chemo-immunotherapy Cervical cancer HPV16-SLP vaccination Immunomonitoring
Challenging the cholinergic system: ageing, cognition & inflammationAlvarez-Jimenez R.Gerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Groeneveld G.J, dr.Universiteit Leiden (UL)2017Neuropsychopharmacology Clinical Pharmacology Trials Cognition Dementia Cholinergis system Drug development
Clinical pharmacology of immuno-modulatory biotherapeutics : innovations in early drug developmentDillingh M.RBurggraaf J., prof. dr.Cohen A.F., prof. dr.Moerland M., Dr.Universiteit Leiden (UL)2017Biotherapeutics Early drug development
Human pharmacology of current and novel gaba(a)-ergic treatments for anxietyChen XGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Jacobs G.E., Dr.Universiteit Leiden (UL)2017Anxiety Human pharmacology GABA-ergic treatment
Anti sense and sensibility : renal and skin effects of (antisense) oligonucleotidesMeer, van L., Dr.Cohen A.F., prof. dr.Burggraaf J., prof. dr.Moerland M., Dr.Universiteit Leiden (UL)2017Oligonucleotide Antisense Type 2 diabetes mellitus Clinical trial Phase2study
Clinical pharmacology of genotype-directed anticancer therapy - Towards rational combination strategiesGeel R.M.J.M. van, PhDSchellens J.H.M., prof. dr.Beijnen J.H., prof. dr.Huitema A.D.R., prof. dr.Cats A., dr.Universiteit Utrecht (UU)2016Cancer; Genetics; BRAF; Colorectal cancer; Combination therapy; p53-deficient ovarian cancer; AZD1775; Treatment individualization;
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillationWiersma M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2016Atrial fibrillation;
Statin treatment in type 2 diabetes patiëntsVries F.M. de, PhDHak E., prof. dr.Denig P., prof. dr.Postma M.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016Statins; Diabetes mellitus;
Drug-related problems: risk factors and the role of clinical pharmacistsZaal R.J., PhDVulto A.G., prof. dr.Haaijer-Ruskamp F.M., prof. dr.Bemt P.M.L.A. van den, dr.Erasmus Universiteit Rotterdam (EUR)2016Drug-related problems; Risk factors;
Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicineSchievink B.H., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016PRE score; Risk markers; Chronic kidney disease; Personalized medicine;
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimatesKröpelin T.F., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016Kidney; Diabetic kidney disease; Drug efficacy;
Clinical pharmacology and therapeutic drug monitoring of first-line anti-tuberculosis drugsSturkenboom M.G.G., PhDKosterink J.G.W., prof. dr.Werf T.S. van der, prof. dr.Uges D.R.A., prof. dr.Alffenaar J.W.C., prof. dr.Rijksuniversiteit Groningen (RUG)2016Tuberculosis; Therapeutic drug monitoring;
Experimental focal cerebral ischemia: optimalisation of models and therapeutic interventionsShanbhag N.C., PhDHenning R.H., prof. dr.Schilling L., prof. dr.Rijksuniversiteit Groningen (RUG)2016Cerebral ischemia;
Adverse drug reactions of angiotensin-converting enzyme inhibitors : towards precicion medicineMahmoud Pour S.H., PhDBoer A. de, prof. dr.Asselbergs F.W., prof. dr. MD FESMaitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2016Adverse drug reaction; Pharmacoepidemiology; Pharmacovigilance; ACE Inhibitors
Tetrahydrocannabinol in the treatment of neuropsychiatric symptoms in dementiaElsen G. van den, PhDOlde Rikkert M., prof. dr.Verkes R., prof. dr.Marck M. van der, dr. ir.Kramers C., dr.Radboud Universiteit (RU)2016THC; geriatric medicine; pain; Dementia;
Methods for improving the safety of fluoropyrimidine anticancer drugsJacobs B.A.W., PhDSchellens J.H.M., prof. dr.Beijnen J.H., prof. dr.Nuijen B., dr.Universiteit Utrecht (UU)2016Fluoropyrimidines; Capecitabine; 5-fluorouracil; Dihydropyrimidine dehydrogenase; Thymidylate synthase; Safety; Phenotyping; Circadian rhythm;
Risk factors and treatment of paediatric chronic diseases - Type 1 diabetes, asthma and allergyAhmadizar F., PhDBoer A. de, prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2016Children; Diabetes mellitus; Allergy
Clinical pharmacology of novel anticancer agents: bioanalysis - clinical pharmacokinetics - mass balance studiesNijenhuis C.M., PhDBeijnen J.H., prof. dr.Schellens J.H.M., prof. dr.Rosing H., dr.Universiteit Utrecht (UU)2016
Medication Optimization; exploring the use of a clinical decision support systemWit H.A.J.M. de, PhDSchols J.M.G.A., prof. dr.Kuy P.H.M. van der, dr.Janknegt R., PharmD PhDUniversiteit Maastricht (UM)2016Clinical pharmacology; Clinical rules; CDSS
Go to page:
  • of 6